Can we predict extraprostatic/metastatic disease on PSMA PET-CT based on PSA, MRI and Gleason grade?

被引：0
|
作者：
Vashistha, Bhanu [1 ]
Puthur, Kurian J. [1 ]
Arunsingh, Moses [1 ]
Das, Jayanta [2 ]
Ray, Soumen [2 ]
Mallick, Indranil [1 ]
机构：
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
[2] Tata Med Ctr, Nucl Med, Kolkata, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
PSMA-PET; Staging; Prostate;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2502
引用
收藏
页码：S2538 / S2539
页数：3
相关论文
共 3 条
  • [1] Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features?
    Laudicella, Riccardo
    Bauckneht, Matteo
    Maurer, Alexander
    Heimer, Jakob
    Gennari, Antonio G.
    Di Raimondo, Tania
    Paone, Gaetano
    Cuzzocrea, Marco
    Messerli, Michael
    Eberli, Daniel
    Burger, Irene A.
    Rahbar, Kambiz
    CANCERS, 2023, 15 (22)
  • [2] Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
    Calabria, Ferdinando
    Chiaravalloti, Agostino
    Tavolozza, Mario
    Ragano-Caracciolo, Cristiana
    Schillaci, Orazio
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (08) : 733 - 740
  • [3] Can 68Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?
    Yin, Haoli
    Chen, Mengxia
    Qiu, Xuefeng
    Qiu, Li
    Gao, Jie
    Li, Danyan
    Fu, Yao
    Huang, Haifeng
    Guo, Suhan
    Zhang, Qing
    Ai, Shuyue
    Wang, Feng
    Guo, Hongqian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) : 3693 - 3701
1